Live Breaking News & Updates on Inovio pharmaceuticals stock down

Stay informed with the latest breaking news from Inovio pharmaceuticals stock down on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Inovio pharmaceuticals stock down and stay connected to the pulse of your community

Inovio Pharmaceuticals (NASDAQ:INO) Cut to Sell at StockNews.com

Inovio Pharmaceuticals (NASDAQ:INO) Cut to Sell at StockNews.com
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Inovio-pharmaceuticals-inc , Inovio-pharmaceuticals , News-ratings-for-inovio-pharmaceuticals-daily , Nasdaq , Inovio-pharmaceuticals-stock-down , Vanguard-group-inc , Millennium-management , Institutional-trading-of-inovio-pharmaceuticals , Renaissance-technologies , Capital-partners , Free-report

Inovio Pharmaceuticals (NASDAQ:INO) Releases Earnings Results, Misses Expectations By $0.02 EPS

Inovio Pharmaceuticals (NASDAQ:INO – Get Rating) announced its earnings results on Wednesday. The biopharmaceutical company reported ($0.16) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.02), RTT News reports. The company had revenue of $0.11 million for the quarter, compared to analyst estimates of $0.20 million. Inovio Pharmaceuticals had […]

Canada , United-states , American , Nasdaq , Ci-private-wealth , Royal-bank , Tower-research-capital , Inovio-pharmaceuticals , Inovio-pharmaceuticals-company-profile , American-century-companies-inc , Earnings-history-for-inovio-pharmaceuticals

Inovio Pharmaceuticals (NASDAQ:INO) Rating Lowered to Underperform at Bank of America

Bank of America cut shares of Inovio Pharmaceuticals (NASDAQ:INO – Get Rating) from a neutral rating to an underperform rating in a research report sent to investors on Tuesday, Marketbeat Ratings reports. The brokerage currently has $2.00 price objective on the biopharmaceutical company’s stock. INO has been the topic of several other research reports. Royal […]

United-states , Canada , America , Davidb-weiner , Northern-trust-corp , Rafferty-asset-management , Analyst-recommendations-for-inovio-pharmaceuticals , Inovio-pharmaceuticals-inc , Institutional-trading-of-inovio-pharmaceuticals , Vanguard-group-inc , Inovio-pharmaceuticals-stock-down